4:10 PM
 | 
Dec 06, 2017
 |  BC Extra  |  Financial News

Editas raises $50M follow-on

Gene editing company Editas Medicine Inc. (NASDAQ:EDIT) said it raised about $50 million through the sale of 1.97 million shares in a follow-on underwritten by Morgan...

Read the full 109 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >